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Insulin-degrading enzyme (IDE)6 is a zinc metallopeptidase
from the M16 family that has been extensively studied because
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of its role in regulating cellular insulin (1–3). More recently,
IDE has received considerable attention for its role in degrading
amyloid ␤ (A␤) peptides (4 –7), and a genetic link between IDE
and late onset Alzheimer disease has been reported (8). IDE
degrades a number of other physiological peptides in vitro,
including IGF-1 and IGF-2 (9), glucagon (10), atrial natriuretic
peptide, TGF-␣ (11), and ␥-endorphin (11). In addition to its
metabolic role in peptide degradation, IDE has been reported to
play a role in the inhibition of proteasome function by insulin
(12), to degrade oxidized proteins in peroxisomes (13), to serve
as a receptor accessory factor that enhances androgen and glucocorticoid receptor binding to DNA (14), and to serve as a
receptor for the Varicella-Zoster virus (15, 16). Thus, IDE has a
central role in mammalian physiology, and modulating its function may prove valuable for the treatment of disease states,
most notably diabetes and Alzheimer disease.
Both the liganded and unliganded structures of human IDE
have been recently reported (17, 18). The tertiary structure
resembles a clamshell composed of four structurally similar
domains arranged to enclose a large central chamber. Substrates must enter the chamber, which has a volume of ⬃13,000
A3, and it is believed that a hinge-like conformational change
allows substrate binding and product release. Mutations that
destabilize the closed conformation increase IDE activity, suggesting that substrate binding/product release may be rate-limiting. The initial structural work (17) as well as our recent studies (19) identify two sites where substrates interact with the
enzyme, one at the active site, located in domain 1, and the
other at an equivalent site in the noncatalytic domain 2.
IDE exists as an equilibrium mixture of monomers, dimers,
and tetramers, with dimers thought to be the predominant and
most active state (11, 20). IDE is unusual among zinc metallopeptidases in that it exhibits allosteric kinetic behavior, with
small peptide substrates increasing the activity of the enzyme
toward the same or other small peptides (20). In addition, IDE
has been shown to be activated heterotropically by polyphosphate anions (21, 22). In particular, ATP, other nucleotides, and
triphosphate (PPPi) activate the enzyme toward hydrolysis of
certain substrates 100 –200-fold (21, 23). More recently, it has
been reported that IDE has ATPase activity, which is also
dependent upon a site distinct from the active site (24). In the
studies presented here, we identify the site where ATP (and
likely other anions) binds to IDE using x-ray crystallography
and show that mutating enzyme residues in this site sharply
decreases ATP/anion activation.
triphosphate; Abz, ortho-aminobenzoic acid; EDDnp, N-(ethylenediamine)2,4-dinitrophenyl.

VOLUME 287 • NUMBER 1 • JANUARY 2, 2012

Downloaded from http://www.jbc.org/ by guest on October 5, 2017

Insulin-degrading enzyme (IDE) (insulysin) is a zinc metallopeptidase that metabolizes several bioactive peptides, including
insulin and the amyloid ␤ peptide. IDE is an unusual metallopeptidase in that it is allosterically activated by both small peptides and anions, such as ATP. Here, we report that the ATPbinding site is located on a portion of the substrate binding
chamber wall arising largely from domain 4 of the four-domain
IDE. Two variants having residues in this site mutated,
IDEK898A,K899A,S901A and IDER429S, both show greatly decreased
activation by the polyphosphate anions ATP and PPPi.
IDEK898A,K899A,S901A is also deficient in activation by small
peptides, suggesting a possible mechanistic link between the
two types of allosteric activation. Sodium chloride at high
concentrations can also activate IDE. There are no observable
differences in average conformation between the IDE-ATP
complex and unliganded IDE, but regions of the active site
and C-terminal domain do show increased crystallographic
thermal factors in the complex, suggesting an effect on
dynamics. Activation by ATP is shown to be independent of
the ATP hydrolysis activity reported for the enzyme. We also
report that IDEK898A,K899A,S901A has reduced intracellular function relative to unmodified IDE, consistent with a possible role for
anion activation of IDE activity in vivo. Together, the data suggest a
model in which the binding of anions activates by reducing the
electrostatic attraction between the two halves of the enzyme, shifting the partitioning between open and closed conformations of
IDE toward the open form.

IDE ATP Site
EXPERIMENTAL PROCEDURES
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Data collection and structure refinement
Resolution
Space group
mol/asymmetric unit
a
b
c
␣
␤
␥

Completenessa
Redundancya
Rsyma
I/a
R/Rfree
Bond lengths
Bond angles
No. of water molecules
Ramachandran favored
Ramachandran outliers
a

IDE-ATP
50.0–2.27 Å
C2
1
115.0 Å
70.7 Å
114.1 Å
90.00°
92.63°
90.00°
0.9794 Å
92.0% (88.7%)
3.3 (2.7)
0.09 (0.48)
11.0 (1.9)
0.22/0.27
0.007 Å
1.04°
226
96.8%
0.0%

Data indicate statistics for the last resolution shell (2.33–2.27 Å) as shown in
parentheses.

tallized with ATP was determined by molecular replacement
with PHASER (31) using the native rat IDE coordinates (19) and
refined using REFMAC5 within CCP4 (Collaborative Computational Project, No. 4) with subsequent model building performed using COOT (32). Water molecules were assigned
using PHENIX (33), CCP4, and COOT. The quality of the final
structure was analyzed using the Molprobity server (34), and
figures were made using PyMOL (PyMOL Molecular Graphics
System) and Chimera (35). Crystallographic data collection and
refinement statistics are summarized in Table 1.
Enzyme Activity Assay—IDE activity was determined by
measuring the increase in fluorescence that occurs when the
enzyme cleaves the internally quenched fluorogenic substrate
Abz-GGFLRKHGQ-EDDnp at the Arg–Lys bond (26). The
reaction was followed on a SpectraMax Gemini XS fluorescence plate reader using excitation and emission wavelengths
of 318 and 419 nm, respectively. Initial velocities were determined using SoftMax Pro 4.0 and kinetic constants calculated
using GraphPad Prism 4.0. ATPase activity was measured by
following Pi release with acid molybdate as described by Harder
et al. (36).
TNP-ATP Fluorescence Measurements—TNP-ATP fluorescence was monitored at excitation and emission wavelengths of
403 and 547 nm, respectively, using an LS55 luminescence
spectrometer (PerkinElmer Life Sciences) at 20 ⫾ 0.1 °C. TNPATP (Molecular Probes, Inc.) as supplied was diluted to 4 mM
with 50 mM Tris-HCl, pH 7.4, and added to achieve the indicated concentrations. Competition experiments used to assess
triphosphate affinity for wild type and mutant IDE were carried
out with 5 M enzyme in 50 mM Tris-HCl, pH 7.4, with constant
10 M TNP-ATP and PPPi varying from 0 to 60 mM. Decrease in
fluorescent enhancement at 547 nm was followed.
IDE Activity Assay in Yeast—Wild type IDE and
IDEK898A,K899A,S901A activities were compared in Saccharomyces cerevisiae using both a serial dilution mating test and a spot
halo assay as described previously (37, 38). The assays take
advantage of the ability of IDE, in lieu of the yeast M16 metallopeptidases Axl1p and Ste23p, to participate in the proteolytic
JOURNAL OF BIOLOGICAL CHEMISTRY
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Preparation of IDE Mutants—Rat IDE (residues 41–1019),
bearing the mutations K898A,K899A,S901A (IDEK898A,K899A,S901A),
or R429S (IDER429S) were prepared from the pFastBac HTb-IDE
plasmid (20, 25) using the QuikChange mutagenesis kit (Stratagene). Primers used for mutagenesis are listed as follows with
the base changes in boldface and underlined: 1) Lys-898, Lys899, and Ser-901 changed to alanine- IDEK898A,K899A,S901A:
K898A forward, 5⬘-CGACTCGACAAACCAGCGAAACTCTCTGCAGAG-3⬘, and reverse, 5⬘-CTCTGCAGAGAGTTTCGCTGGTTTGTCGAGTCG-3⬘; K899A forward, 5⬘-CTCGACAAACCAGCGGCACTCTCTGCAGAGTGC-3⬘, and
reverse, 5⬘-GCACTCTGCAGAGAGTGCCGCTGGTTTGTCGAG-3⬘; S901A forward, 5⬘-AAACCAGCGGCACTCGCTGCAGAGTGCGCGAAG-3⬘, and reverse, 5⬘-CTTCGCGCACTCTGCAGCGAGTGCCGCTGGTTT-3⬘; 2) Arg-429
converted to serine IDER429S, R429S forward, 5⬘-TTTAAAGATAAAGAGAGCCCACGAGGCTACACA-3⬘, and reverse,
5⬘-TGTGTAGCCTCGTGGGCTCTCTTTATCTTTAAA-3⬘.
Bacmid and virus production were as discussed previously (25,
26).
Purification of IDE—IDE and the IDEK898A,K899A,S901A and
IDER429S mutants were expressed as hexahistidine fusion proteins (hexahistidine sequence and a linker containing a tobacco
etch virus protease cleavage site) in Sf9 cells and purified as
described previously (25, 26). Briefly, Sf9 cells were suspended
in 100 mM potassium phosphate buffer, pH 7.3, sonicated, and
centrifuged at 75,000 ⫻ g for 20 min to pellet the membrane
fraction. Supernatant was loaded on a His-select nickel affinity
gel (Sigma) column and washed extensively with the potassium
phosphate buffer containing 20 mM imidazole. Enzyme was
eluting from the metal affinity resin by proteolytic removal of
the hexahistidine sequence with added tobacco etch virus protease. IDE activity is known to be similar before and after cleavage of the hexahistidine fusion sequence (27). Purity was estimated by SDS-polyacrylamide gel analysis, and protein
concentration was determined using the Coomassie Blue reagent with BSA as a standard.
Crystallization of IDE in Presence of ATP—Co-crystallization
of wild type IDE and ATP was performed using IDE at 8 mg/ml
in 50 mM Tris, pH 7.4, 1 mM DTT, 50 –100 mM NaCl, 5 mM
ATP, and 1 mM EDTA. The enzyme was maintained for 4 days
under the above conditions before being used for crystallization
trials employing the sitting drop vaporization method with
Compact Clover plates (Emerald Biosystems). EDTA was used
primarily to sequester any free Mg2⫹, which has been shown to
reduce activation by ATP (21, 23). The protein/ATP solution
was mixed 1:1 with well solution containing 100 mM sodium
citrate, pH 6.5, 100 mM ammonium acetate, and 20% PEG 4000,
and crystals were grown at 22 °C, usually accompanied by heavy
precipitation. Crystals were dehydrated (28) by a brief (1–5 s)
transfer to 50% PEG 4000 prior to flash cooling in liquid nitrogen (29).
Data Collection and Structure Determination—Final data
were collected at Beamline-X4C of the National Synchrotron
Light Source at Brookhaven National Laboratory, and the data
were processed using HKL2000 (30). The structure of IDE crys-

TABLE 1
Crystallographic summary of data collection and structure determination for the IDE-ATP complex crystal structure

IDE ATP Site
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backbone bonds. Surface views were prepared with the program Chimera (35) using APBS and PDB2PQR for electrostatic
calculations (48).

RESULTS
IDE-ATP Complex Crystal Structure—Previous studies have
shown that the polyphosphate anions ATP and PPPi act in vitro
as heterotropic activators of IDE toward the hydrolysis of small
peptides, including the fluorogenic substrate Abz-GGFLRKHGQ-EDDnp (21, 26). To determine the interactions
important for ATP binding in IDE, we crystallized rat IDE in the
presence of ATP and determined the structure of the enzyme at
2.27 Å by molecular replacement using our previously determined native rat IDE coordinates (19). A difference electron
density map revealed the presence of two bound ligands. The
first region of strong positive difference density was at the previously described distal binding site (17). Attempts to model in
the triphosphate moiety of ATP into the positive electron density at this site resulted in several unfavorable contacts with the
enzyme. We have found that cleavage of the N-terminal hexahistidine tag from inactive IDE leads to binding of cleaved peptide derived from the fusion sequence at the distal site (19), and
a three-residue polyalanine peptide modeled into this site
accounted for most of the observed electron density.
The second ligand site is located on the inner surface of
domain 4 (the loop between helices ␣31 and ␣32) near the
interfaces with domains 2 and 3. The observed difference electron density was consistent with bound ATP, and a model for
the ligand was placed at this site (Fig. 1, A and B). Electron
density for the adenine ring of the ATP molecule was absent,
indicating that this portion of the molecule is disordered. This
observation agrees with previous studies suggesting that ATP
binding occurs exclusively through the triphosphate moiety
(21, 23). In prior work, crystal structures of rat IDE were determined under the same crystallization and data collection conditions except that ATP (and EDTA) were not present (19).
Importantly, these structures do not show strong connected
difference density in the proposed ATP-binding site (Fig. 1C),
indicating that the density seen in this region is due to ATP and
not another component of the buffer.
The model of ATP binding suggests several potential interactions with the enzyme (Fig. 2). The side chains of residues
Arg-429, Lys-898, Lys-899, and Ser-901 are in position to
potentially make hydrogen bond interactions with the modeled
ATP ligand. Also the amide nitrogen of Lys-898 is well positioned to hydrogen bond with the phosphate groups in the
model. Arg-429 is the only domain 2 residue that might contribute to ATP binding. It may be somewhat analogous to an
arginine finger found in some other GTP- and ATP-hydrolyzing proteins (49, 50), where the charge on the guanidinium
group stabilizes additional negative charge development during
the transition state of ATP hydrolysis. It should be noted that
the high micromolar affinity of IDE for ATP/polyphosphates
suggests that these residues do not make strong contacts with
the bound ligand.
A structural alignment of the IDE-ATP complex with the
native IDE crystal structure (19) did not reveal any significant
changes in average conformation at the ATP-binding site.
VOLUME 287 • NUMBER 1 • JANUARY 2, 2012
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maturation of yeast a-factor mating pheromone. In the mating
test, IH1793 cells (MAT␣ lys1 (39)) were mixed with decreasing
numbers of strain Y272 cells (MATa trp1 leu2 ura3 his4 can1
axl1::LEU2 ste23::LEU2) bearing expression plasmids encoding
IDE (pWS839; 2 URA3 PPGK-HIS6n::TEV::IDE(41–1019)),
IDEK898A,K899A,S901A (pWS841; 2 URA3 PPGK-HIS6n::
TEV::IDE(41–1019)K898A,K899A,S901A), or an empty expression vector (pRS316 (40)). The initial ratio of MAT␣ to MATa
cells was 9:1 in a 100-l volume, with subsequent mixtures
having sequentially 10-fold less MATa cells. Portions of mating
mixtures (10 l) were spotted on minimal media. Growth of
diploid colonies, indicative of mating, was scored 3 days after
incubation of plates at 30 °C. For the halo assay, yeast bearing
the expression plasmids listed above were cultured in 5 ml of
selective media for 3 days at 30 °C in 15-ml conical polypropylene tubes, which adsorb a-factor on their walls. The adsorbed
a-factor was extracted by voiding the contents of the culture,
washing the tubes several times with deionized water, and desorbing a-factor with methanol. Recovered a-factor samples
were dried by speed-vac, and samples were reconstituted in
methanol (50 l). 2-Fold serial dilutions of the samples were
prepared in YEPD liquid media, and a portion (2 l) of each
dilution was spotted onto a lawn of RC757 cells (MAT␣ lys1
sst2-1 (41)) that had been spread on YEPD solid media; RC757
yeast undergo a strong growth arrest phenotype in the presence
of a-factor (42). Halo formation was allowed to proceed for 18 h
at 30 °C. Results of mating tests and halo assays were recorded
by scanning plates with a Microtek flatbed scanner and importing digitized images into Photoshop and PowerPoint.
Construction of Yeast Expression Vectors Encoding IDE—
pWS839 and pWS841 were created by plasmid-based PCR-directed recombination (43). In brief, the IDE encoding
sequences were amplified by PCR from the pFastBac HTb vectors described above (IDE and IDEK898A,K899A,S901A) such that
the ends of the PCR products contained the desired coding
region and 39-bp extensions on either end that were homologous to the expression vector (pSM703 (44), 2 URA3 PPGK) at
sites on opposite sides of the polylinker. The PCR product was
co-transformed into Y272 yeast along with pSM703 that had
been digested with XmaI and NotI. Plasmids were isolated from
yeast colonies surviving selection and screened for the presence
of an appropriate insert by restriction digest analysis.
Preparation of Yeast Cell Extracts and Immunoblotting—
Yeast extracts for immunoblot analysis were generated by alkaline lysis and TCA precipitation as described previously (45).
The recovered protein precipitates were resuspended in hot
(100 °C) urea sample buffer (250 mM Tris, pH 8.0, 6 M urea, 4%
SDS, and 0.01% bromphenol blue) and clarified by centrifugation before use (16,000 ⫻ g, 1 min). An equivalent percentage
amount of each sample was subject to SDS-PAGE followed by
immunoblot analysis using an IDE-specific antibody, an appropriate secondary antibody, and chemiluminescence detection
methods (BM Chemiluminescence Blotting Substrate, Roche
Applied Science).
Docking of Triphosphate—Docking of triphosphate to the
inner surface of domains 3 and 4 was done with AutoDock Vina
(46) and AutoDockTools (47). The search region was defined
interactively, and rotational flexibility was allowed for all ligand

IDE ATP Site

FIGURE 1. ATP density. A, SIGMAA weighted 2Fo ⫺ Fc electron density map
(blue) in the region of the ATP-binding site is displayed at 0.8 of the root mean
square deviation of the map. The final model is shown in a stick representation.
B, difference electron density (Fo ⫺ Fc) used for initial placement of ATP. The
density (displayed with a cutoff of 2.3 times the root mean square deviation of
the map) was phased from the IDE model after molecular replacement and
initial refinement. The final ATP model is shown in a line representation. C,
simulated annealing omit difference electron density (Fo ⫺ Fc, 2.3 times the
root mean square deviation of the map) in the region of the ATP-binding site
from an IDE crystal structure determined in the absence of ATP (19). Crystallization and data collection conditions were the same as used for the ATPbound structure except ATP and EDTA were not included in the final soaking
solution.

However, a comparison of the thermal factors for native IDE
and the IDE-ATP crystal structures (which are essentially isomorphous and were determined at nearly the same resolution)
suggest a global change in dynamics of IDE upon binding ATP
(supplemental Fig. S1). In particular, higher thermal factors are
observed for many of the residues within the catalytic domain
of IDE. The average thermal factor on all atoms of the catalytic
JANUARY 2, 2012 • VOLUME 287 • NUMBER 1

domain (residues 42–285) of IDE is 29.5 Å2 as compared with a
value of 49.9 Å2 for the same residues of IDE-ATP. Overall, the
two models have similar thermal factors, with an average value
of 39.4 for all unliganded IDE protein atoms and 42.4 for all
IDE-ATP protein atoms, indicating that the differences in the
catalytic domain are not the result of an overall difference in the
two crystal structures.
Mutagenesis and Biochemical Analysis of ATP-binding Site of
IDE—Site-directed mutagenesis was used to eliminate potential binding interactions identified in the crystal structure. Two
mutant forms of IDE were generated, the first with mutations
K898A,K899A,S901A (IDEK898A,K899A,S901A), and the second
with the single mutation R429S (IDER429S). With the synthetic
substrate Abz-GGFLRKHGQ-EDDnp, both mutants retained
the sigmoidal substrate versus velocity response observed with
IDE (Fig. 3), which is characteristic of allosteric homotropic
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 2. Overview of IDE structure and details of proposed ATP-binding
site. A, backbone trace of IDE crystallized in the presence of ATP is shown in a
ribbon representation with the four structurally related domains numbered,
and the N- and C-terminal halves of the molecule colored in cyan and yellow,
respectively. The expected position of the active site zinc ion is shown as a
yellow sphere, but the metal is absent in the crystal structure. The region
believed to act as a hinge for a proposed conformational change is also indicated. Modeled ATP and a 3-mer polyalanine peptide are shown in a spacefilling representation and indicated by labels. B, proposed ATP-binding site is
shown with selected side chains in a stick representation and ordered water
as red spheres. ATP modeled into difference density present in the site is also
show in stick representation.

IDE ATP Site
TABLE 2
Summary of kinetic properties of IDE, IDER429S, and
IDEK898A,K899A,S901A with Abz-GGFLRKHGQ-EDDnp as a substrate
Vmax (nmol/min/mg)
kcat (min⫺1)
Km (mM)
Hill coefficient

IDE

IDER429S

47.2 ⫾ 1.7
5.2 ⫾ 0.2
9.6 ⫾ 0.7
2.1 ⫾ 0.3

42.3 ⫾ 3.2
4.7 ⫾ 0.3
21.3 ⫾ 2.4
1.7 ⫾ 0.2

IDEK898A,K899A,S901A
140.8 ⫾ 5.5
15.5 ⫾ 0.6
17.3 ⫾ 1.0
1. 7 ⫾ 0.1

Downloaded from http://www.jbc.org/ by guest on October 5, 2017

FIGURE 3. Comparison of kinetics of IDE and IDE containing ATP-binding
site mutations. Reactions were conducted in 50 mM Tris-HCl, pH 7.4, with IDE
(0.5 g) (A), IDEK898A,K899A,S901A (0.5 g) (B), or IDER429S (1.0 g) (C) using AbzGGFLRKHGQ-EDDnp as the substrate.

activation (20). Hill coefficients of 1.7 were calculated for both
mutants, which is slightly less than the value of 2.1 obtained for
IDE. The IDEK898A,K899A,S901A mutant showed a 3-fold increase
in kcat relative to IDE, whereas IDER429S had essentially the
same kcat as IDE (Table 2). Both mutants had a roughly 2-fold
higher Km values for the fluorogenic substrate compared with
IDE.
The ability of ATP, triphosphate, and TNP-ATP to activate
both IDE mutants is dramatically reduced relative to the wild
type enzyme, however (Fig. 4). ATP activates IDE more than
100-fold with Abz-GGFLRKHGQ-EDDnp as the substrate.
The level of IDER429S activation is about 35% of the wild type
enzyme value, and there is even less activation of
IDEK898A,K899A,S901A by ATP, ⬃15%. The concentration of ATP
needed to achieve 50% activation (Ka) appears to be ⬃2-fold
lower for the mutants than the wild type enzyme (Ka ⫽ 1.6 mM
for IDE and 0.6 mM for both IDEK898A,K899A,S901A and
IDER429S). However as noted by Dixon and Webb (51) these Ka
values do not directly reflect the affinity of the enzyme for ATP
as they are dependent of the Km for the substrate, which is

52 JOURNAL OF BIOLOGICAL CHEMISTRY

FIGURE 4. Effect of ATP-binding site mutations on the ability of ATP, PPPi,
and TNP-ATP to increase the rate of Abz-GGFLRKHGQ-EDDnp hydrolysis. Activity was determined in 50 mM Tris-HCl, pH 7.4, with 10 M Abz-GGFLRKHGQ-EDDnp as substrate at the indicated concentrations of ATP (A), PPPi
(B), or TNP-ATP (C). Each reaction contained 0.5 g of enzyme. Relative activity
is the ratio of substrate cleaved at a given concentration of polyphosphate
species to that cleaved in the absence of the polyphosphate species. IDE,
closed circles; IDER429S, closed triangles; IDEK898A,K899A,S901A, closed squares.

⬃2-fold higher for each of the mutants. In addition, the steadystate equation contains terms in [A]2 and [S]2 making the
apparent Ka a complex constant. Activation by triphosphate
showed essentially the same apparent Ka or wild type IDE and
the IDER429S mutant (0.08 and 0.09 mM, respectively) but a
higher apparent Ka for IDEK898A,K899A,S901A (0.5 mM). Activation by TNP-ATP showed an increased apparent Ka for
IDEK898A,K899A,S901A and IDER429S mutant (2.2 M) compared
with a Ka of 0.9 M for the wild type enzyme.
Both mutants bound TNP-ATP with a greater fluorescent
enhancement than IDE (Fig. 5, top spectrum in each panel). We
VOLUME 287 • NUMBER 1 • JANUARY 2, 2012
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FIGURE 5. Displacement of bound TNP-ATP by triphosphate. Fluorescence
emission spectra were recorded in 50 mM Tris-HCl, pH 7.4, with 10 M TNPATP, 5 M IDE, or IDE mutant and the indicated concentration of PPPi.

measured the ability of PPPi to displace bound TNP-ATP
because high concentrations of ATP interfered with the TNPATP fluorescence spectra. As seen in Fig. 5, PPPi can completely displace bound TNP-ATP from IDE with half-maximal
displacement at 0.6 mM PPPi. For the two NEP mutants, we
found that TNP-ATP displacement was incomplete with
half-maximal displacement at ⬃1.3 mM PPPi for
IDEK898A,K899A,S901A and ⬃1.0 mM for IDER429S. These higher
half-maximal displacement concentrations suggest a weaker
binding to the mutant IDE forms. The inability of PPPi to comJANUARY 2, 2012 • VOLUME 287 • NUMBER 1

pletely displace TNP-ATP from the mutants further suggests
an alteration in the local environment of the binding site. In
particular, it suggests a less electrostatic/polar character to the
interaction. Taken together, these kinetic and analog binding
results are consistent with the IDEK898A,K899A,S901A and
IDER429S mutations affecting the binding of ATP, likely through
a decrease in affinity as well as a change in the orientation or
location of the bound molecule.
The activity of wild type IDE with Abz-GGFLRKHGQEDDnp as substrate is increased by high concentrations of NaCl
to an even greater extent than by ATP (Fig. 6). As observed with
ATP activation, the two mutants are also activated but to a
lesser extent (Fig. 6). In the presence of 0.2 mM ATP (producing
an ⬃30-fold activation of IDE), ATP-dependent heterotropic
activation is first reduced by NaCl, but then activation is
observed (Fig. 6, inset). As shown in Table 2, activation by NaCl
is about 2-fold greater than activation by ATP for IDE and
IDEK898A,K899A,S901A but close to 4-fold greater with IDER429S.
That NaCl can completely displace ATP (TNP-ATP) from
IDE is shown in Fig. 7. As observed with PPPi, TNP-ATP displacement from IDEK898A,K899A,S901A and IDER429S is incomplete. As also seen with PPPi (Fig. 5), displacement of TNP-ATP
from IDEK898A,K899A,S901A was the least complete. These effects
of salt concentration on IDE activity are supportive of an electrostatic mechanism for anion activation.
We have previously shown that small peptides like bradykinin can act as activators of Abz-GGFLRKHGQ-EDDnp
hydrolysis, and interactions between peptide and anion activation have been suggested (20). We thus determined the effect
ATP-binding site mutations would have on the ability of bradykinin to increase the rate of Abz-GGFLRKHGQ-EDDnp
hydrolysis. Similar rates were observed for IDER429S and wild
type IDE, although the observed rate for IDEK898A,K899A,S901A
was significantly reduced, suggesting that ATP- and peptidedependent activation may be linked (Fig. 8).
IDE has been reported to exhibit ATPase activity (24). Thus
the question arises as to whether activation of IDE by ATP is
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 6. Effect of NaCl on IDE-dependent hydrolysis of Abz-GGFLRKHGQ-EDDnp hydrolysis and on activation by ATP. Activity was determined in 50 mM Tris-HCl, pH 7.4, with 10 M Abz-GGFLRKHGQ-EDDnp as substrate, IDE, IDEK898A,K899A,S901A, or IDER429S, and the indicated concentration of
NaCl. The effect of NaCl was determined in the absence (closed symbols) or
presence (open symbols) of 0.2 mM ATP. The inset shows that NaCl initially
inhibited but then activated the reaction in the presence of ATP.

IDE ATP Site

FIGURE 8. Effect of bradykinin on Abz-GGFLRKHGQ-EDDnp hydrolysis by
IDE, IDEK898A,K899A,S901A, or IDER429S. Activity was determined in 50 mM TrisHCl, pH 7.4, with 10 M Abz-GGFLRKHGQ-EDDnp as substrate and indicated
concentrations of bradykinin. Reactions contained 0.5 g of protein.

TABLE 3
Comparison of activation by ATP to activation by NaCl
Rate increase at 5 mM ATP

Rate increase at 2 M NaCl

IDE
IDE-AAA
IDER429S

102
16
37

228
27
130

ATP-binding site mutant IDEK898A,K899A,S901A were produced
at approximately the same protein levels (Fig. 9A). Wild
type IDE, however, promoted mating to a greater extent than
IDEK898A,K899A,S901A (Fig. 9B). Similarly, a spot halo assay
revealed greater production of a-factor by yeast expressing wild
type IDE relative to yeast expressing the ATP-binding site
mutant (Fig. 9C). The results indicate that an intact polyphosphate/anion-binding site is required for maximal IDE activity in
yeast, suggesting that heterotropic activation by anions likely
influences IDE activity in vivo.

FIGURE 7. Displacement of bound TNP-ATP by NaCl. Fluorescence emission spectra were recorded as in Fig. 6 in 50 mM Tris-HCl, pH 7.4, with 10 M
TNP-ATP, 5 M IDE or IDE mutant, and the indicated concentration of NaCl.

coupled to its hydrolysis. We found that the nonhydrolyzable
ATP analog ␥-methylene ATP is able to activate Abz-GGFLRKHGQ-EDDnp hydrolysis nearly as well as ATP (supplemental Fig. S2), demonstrating that ATP hydrolysis is not necessary
for IDE activation. IDE-dependent ATPase activity was estimated to be less than 1 nmol/min/mg IDE using 1 mM ATP as
substrate, and this rate did not change in the presence of AbzGGFLRKHGQ-EDDnp substrate. The much higher rate of
peptide cleavage (see Table 3) over ATP hydrolysis also supports the conclusion that ATPase activity is not coupled to
activation.
Effect of ATP-binding Site Mutation on Intracellular Activity
of IDE—An established yeast system for functional studies of
IDE (37, 38) was used to assess the significance of anion activation on IDE activity in a cellular environment. The assay is
based on the ability of IDE to support production of mature
a-factor mating pheromone in the absence of yeast metallopeptidases (i.e. Axl1p and Ste23p) that normally promote its maturation. When expressed in this yeast system, IDE and the
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DISCUSSION
ATP-binding Site of IDE—A number of observations suggest
that the site identified by crystallography is indeed the site
where ATP and presumably other anions bind. Mutating
nearby basic residues, as well as Ser-901, in the IDER429S and
IDEK898A,K899A,S901A variants profoundly affects the level of
heterotropic activation by ATP. In addition, these mutations
affect the interaction of TNP-ATP with the enzyme. The fluorescent yield from the TNP group is altered in the mutant IDE
constructs, suggesting a change in the environment local to the
binding site. Also, we find that PPPi and NaCl can completely
compete off the bound TNP-ATP from the wild type enzyme
but not with the two IDE mutants, particularly
IDEK898A,K899A,S901A. This result again suggests a change in the
local environment, in this case one that increases the nonpolar
nature of the TNP interaction, which would then not be disrupted by an increase in ionic strength. The conversion of
nearby charged and polar residues to nonpolar alanine in the
IDEK898A,K899A,S901A mutant could arguably result in just that
effect. Finally, a structural similarity search (DaliLite version 3)
using domains 3 and 4 of IDE identifies a number of related
enzymes that have nucleotide substrates (supplemental Fig.
S3A). In particular, IDE has structural similarity with polymerases and other nucleotidyltransferases, adenylyl cyclase,
and GTP cyclohydrolase III, all palm domain-containing
VOLUME 287 • NUMBER 1 • JANUARY 2, 2012
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enzymes (52), and the nucleotide-binding positions in these
enzymes at least partially overlap the identified ATP-binding
site in IDE.
We anticipated that mutating IDE residues in the polyphosphate-binding site would greatly decrease affinity and thus alter
the concentration dependence of activation by ATP. The mutations do decrease triphosphate binding, another observation
that supports correct identification of the site, but the affinity
loss is less than anticipated. One explanation for this unexpected observation is that there may be alternative binding
interactions that compensate for these mutations. As noted, the
proposed ATP/anion-binding site is located in a larger posiJANUARY 2, 2012 • VOLUME 287 • NUMBER 1
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FIGURE 9. Activity of wild type IDE and ATP-binding site mutant
IDEK898A,K899A,S901A in the yeast S. cerevisiae. A, immunoblot of yeast-expressed IDE and IDEK898A,K899A,S901A. Equivalent percentage amounts of total
cellular extracts from yeast containing an empty expression vector or plasmids encoding IDE or the IDEK898A,K899A,S901A mutant were analyzed by SDSPAGE and immunoblotting using an IDE-specific antibody. B, mating test for
IDE activity. An excess of MAT␣ yeasts were mixed with decreasing numbers
of MATa cells deficient for Axl1p and Ste23p that were transformed with
either an empty expression vector or a vector encoding IDE or
IDEK898A,K899A,S901A as indicated. Mating, which leads to colony growth, is
dependent on production of mature a-factor pheromone by plasmid-encoded IDE. C, spot halo assay for a-factor production. Concentrated samples
of a-factor recovered from yeast bearing the indicated expression vector
were spotted at the indicated dilutions on a lawn of RC757 MAT␣ cells, which
undergo growth arrest upon exposure to a-factor pheromone. The zones of
growth arrest are the dark circular regions within the yeast lawn.

tively charged inner surface formed by domains 3 and 4 (supplemental Fig. S3B). Given the size of the electropositive patch,
there are a number of potential sites for ATP/polyphosphate
binding in addition to the one identified crystallographically,
and this likely holds true for other anions as well. The presence
of alternative sites is supported by computational docking of
triphosphate to the surface, which finds a number of binding
modes clustered not only at the identified site but also at two
nearby locations (supplemental Fig. S3C). The estimated interaction strengths differ by less than 0.7 kcal/mol for all 18
docked triphosphate groups shown, indicating that other sites
might have affinities close to that of the primary site.
We propose then that we have identified a preferred binding
site that under crystallization solution conditions has higher
occupancy than other possible sites. Binding to this site would
reduce affinity for the nearby sites by making the surrounding
surface less electropositive, resulting in the observed one-toone binding stoichiometry (21). Mutating this site, however,
would likely allow alternative binding to nearby sites at a not
greatly diminished affinity, giving activation over a similar concentration range. In this model, binding at the specific site
would activate IDE to a greater extent than binding at nonspecific sites. This would account for the sharp decrease in the
extent of activation when the identified site is ablated. Activation would still occur but only to the lower extent supported by
binding to an alternative site or sites.
The greater activity of wild type IDE over
IDEK898A,K899A,S901A in the yeast assays suggests that anions are
important in determining the level of IDE activity in vivo. Typical intracellular nucleoside triphosphate concentrations (53)
match the observed activation range for IDE (21, 22), but most
nucleotides in the cell are complexed with divalent cations,
likely reducing their effectiveness in activating the enzyme (21).
Also, the low millimolar chloride concentrations in the cytosol
are insufficient to play a significant role in IDE activation based
on our results. Other small anionic species present in cells (54),
including inositol and other sugar phosphates, small glycosaminoglycans, metabolic intermediates (pyruvate, lactate, malate,
oxaloacetate, etc.), and peptides, may contribute, however. Glutathione, which carries a net negative charge, may be a contributor to activation depending on binding affinity, because it is
present in the cytosol at millimolar concentrations. Activation
of the insulin receptor transiently increases the intracellular
concentration of glucose 6-phosphate in animal cells, and a role
for this anion in IDE activation would be attractive from a regulatory perspective. Preliminary assays indicate that 1 mM glucose 6-phosphate produces a 2-fold activation of IDE on a small
substrate, suggesting it may indeed contribute to intracellular
IDE activity. It should be noted, however, that anionic activation of IDE may be constitutive and not regulatory. Further
work will be required to determine the anion or anions primarily responsible for IDE activation in cells and whether their
levels vary sufficiently to modulate IDE activity.
Determining the relevance of enhanced IDE activity will also
require additional studies, particularly because IDE is known to
be involved in a number of physiological functions. In vitro,
ATP/polyphosphate does not greatly enhance IDE activity
toward two important large substrates, insulin and A␤ (21, 22,

IDE ATP Site
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ATP as observed by Im et al. (18) are likely not related to its
ability to increase substrate hydrolysis.
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55). However, identified activators that appear to bind at the
ATP/anion site have been shown to stimulate A␤ hydrolysis by
IDE when another competing peptide is present (55). It may be
that in the complex multisubstrate environment of the cell,
anions increase hydrolysis of insulin and A␤ in the same
manner.
Potential Activation Mechanism—The location of the ATP/
anion-binding site determined in this work suggests a possible
mechanism for activation by polyphosphate/polyanion binding. Previous studies by Tang and co-workers (17, 18) have indicated that the proposed hinge-like conformational change necessary for substrate entry/product release is likely rate-limiting.
Heterotropic activation may occur through a shift in the conformational equilibrium toward the open state of the enzyme,
because ATP binding is accompanied by an increase in the
hydrodynamic radius of IDE (18). The inner surface of the IDE
substrate-binding chamber contributed by domains 3 and 4
carries a strong positive electrostatic potential, whereas the
inner surface contributed by domains 1 and 2 is strongly negative (see supplemental Fig. S3B). Thus binding of anions to the
positively charged half of the chamber likely reduces the electrostatic attraction between the two chamber walls, increasing
the open state population. This electrostatic mechanism is consistent with the activation of IDE by salt, because higher ionic
strength would also reduce the electrostatic attraction between
the two walls of the binding chamber. In fact, high concentrations of the small chloride ion may shield the attractive interactions of the two surfaces more effectively than larger polyanions, resulting in the observed greater activation. This
mechanism also may explain why IDEK898A,K899A,S901A, which
reduces the overall charge on the positively charged half of the
chamber, shows an ⬃3-fold higher kcat than the wild type
enzyme. In addition, the increased thermal motion seen for the
catalytic domain in the crystal structure may result from a loosening of the interface between the two halves of IDE. The lack of
polyphosphate/polyanion activation for large substrates may
reflect their ability to shield electrostatic attraction between the
chamber walls. Larger substrates may also block polyphosphate/anion binding to the specific site.
The conformation of the structurally related enzyme pitrilysin is of interest regarding the proposed activation mechanism.
The two inner chamber walls of this enzyme (Protein Data Bank
accession code 1Q2L) both carry an overall negative surface
charge, and it has been crystallized only in the open conformation. Thus, in pitrilysin repulsion between two negatively
charged surfaces likely plays a role in stabilizing the open form,
just as attraction between two oppositely charged surfaces may
stabilize the closed form of IDE.
Im et al. (18) reported that ATP induced a conformational
change in human IDE, specifically an increase in the ␤-sheet
character as determined by CD spectroscopy. Although we
noted increased thermal factors largely in the catalytic domain,
we did not detect any significant change in the average IDE
structure when ATP was bound. Interestingly, triphosphate,
which is as effective as ATP at increasing IDE activity (Fig. 4)
(21), did not produce the same conformational changes as ATP
(18). This suggests that the conformational effects produced by

IDE ATP Site

JANUARY 2, 2012 • VOLUME 287 • NUMBER 1

43. Oldenburg, K. R., Vo, K. T., Michaelis, S., and Paddon, C. (1997) Nucleic
Acids Res. 25, 451– 452
44. Zhang, Y., Nijbroek, G., Sullivan, M. L., McCracken, A. A., Watkins, S. C.,
Michaelis, S., and Brodsky, J. L. (2001) Mol. Biol. Cell 12, 1303–1314
45. Fujimura-Kamada, K., Nouvet, F. J., and Michaelis, S. (1997) J. Cell Biol.
136, 271–285
46. Trott, O., and Olson, A. J. (2010) J. Comput. Chem. 31, 455– 461
47. Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., and Olson, A. J. (2009) J. Comput. Chem. 30, 2785–2791
48. Unni, S., Huang, Y., Hanson, R. M., Tobias, M., Krishnan, S., Li, W. W.,
Nielsen, J. E., and Baker, N. A. (2011) J. Comput. Chem. 32, 1488 –1491
49. Ahmadian, M. R., Stege, P., Scheffzek, K., and Wittinghofer, A. (1997) Nat.
Struct. Biol. 4, 686 – 689
50. Nadanaciva, S., Weber, J., Wilke-Mounts, S., and Senior, A. E. (1999) Biochemistry 38, 15493–15499
51. Dixon, M., and Webb, E. C. (1979) The Enzymes, 3rd Ed., pp. 381–399,
Academic Press, New York
52. Beese, L. S., Derbyshire, V., and Steitz, T. A. (1993) Science 260, 352–355
53. Beis, I., and Newsholme, E. A. (1975) Biochem. J. 152, 23–32
54. Jones, L. S., Yazzie, B., and Middaugh, C. R. (2004) Mol. Cell. Proteomics 3,
746 –769
55. Cabrol, C., Huzarska, M. A., Dinolfo, C., Rodriguez, M. C., Reinstatler, L.,
Ni, J., Yeh, L. A., Cuny, G. D., Stein, R. L., Selkoe, D. J., and Leissring, M. A.
(2009) PLoS One 4, e5274

JOURNAL OF BIOLOGICAL CHEMISTRY

57

Downloaded from http://www.jbc.org/ by guest on October 5, 2017

roni, L. C., and Read, R. J. (2007) J. Appl. Crystallogr. 40, 658 – 674
32. Emsley, P., and Cowtan, K. (2004) Acta Crystallogr. D Biol. Crystallogr. 60,
2126 –2132
33. Adams, P. D., Grosse-Kunstleve, R. W., Hung, L. W., Ioerger, T. R., McCoy, A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K., and
Terwilliger, T. C. (2002) Acta Crystallogr. D Biol. Crystallogr. 58,
1948 –1954
34. Lovell, S. C., Davis, I. W., Arendall, W. B., 3rd, de Bakker, P. I., Word, J. M.,
Prisant, M. G., Richardson, J. S., and Richardson, D. C. (2003) Proteins
Struct. Funct. Genet. 50, 437– 450
35. Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt,
D. M., Meng, E. C., and Ferrin, T. E. (2004) J. Comput. Chem. 25,
1605–1612
36. Harder, K. W., Owen, P., Wong, L. K., Aebersold, R., Clark-Lewis, I., and
Jirik, F. R. (1994) Biochem. J. 298, 395– 401
37. Kim, S., Lapham, A. N., Freedman, C. G., Reed, T. L., and Schmidt, W. K.
(2005) J. Biol. Chem. 280, 27481–27490
38. Alper, B. J., Nienow, T. E., and Schmidt, W. K. (2006) Biochem. J. 398,
145–152
39. Michaelis, S., and Herskowitz, I. (1988) Mol. Cell. Biol. 8, 1309 –1318
40. Sikorski, R. S., and Hieter, P. (1989) Genetics 122, 19 –27
41. Chan, R. K., and Otte, C. A. (1982) Mol. Cell. Biol. 2, 11–20
42. Marcus, S., Xue, C. B., Naider, F., and Becker, J. M. (1991) Mol. Cell. Biol.
11, 1030 –1039

Anion Activation Site of Insulin-degrading Enzyme
Nicholas Noinaj, Eun Suk Song, Sonia Bhasin, Benjamin J. Alper, Walter K. Schmidt,
Louis B. Hersh and David W. Rodgers
J. Biol. Chem. 2012, 287:48-57.
doi: 10.1074/jbc.M111.264614 originally published online November 2, 2011

Access the most updated version of this article at doi: 10.1074/jbc.M111.264614
Alerts:
• When this article is cited
• When a correction for this article is posted

Supplemental material:
http://www.jbc.org/content/suppl/2011/11/02/M111.264614.DC1
This article cites 54 references, 23 of which can be accessed free at
http://www.jbc.org/content/287/1/48.full.html#ref-list-1

Downloaded from http://www.jbc.org/ by guest on October 5, 2017

Click here to choose from all of JBC's e-mail alerts

